Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2032

Conditions

Limited Stage Small Cell Lung Cancer

Interventions

DRUG

JS004

Specified dose on specified days.

DRUG

Toripalimab

Specified dose on specified days.

PROCEDURE

surgery

Patients with resectable tumors after neoadjuvant therapy will be treated with surgery.

DRUG

Etoposide

Specified dose on specified days.

DRUG

Platinum

Specified dose on specified days.

Trial Locations (1)

RECRUITING

Shanghai Pulmonary Hospital, Shanghai

All Listed Sponsors

lead

Shanghai Pulmonary Hospital, Shanghai, China

OTHER